ICD-10-CM Billable Code

C75.0

Malignant neoplasm of parathyroid gland

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the parathyroid gland, classified under ICD-10 code C75.0, is a rare form of cancer that originates in the parathyroid glands—small glands located in the neck near the thyroid. These glands are responsible for regulating calcium levels in the body through the production of parathyroid hormone (PTH). When cancer develops in the parathyroid glands, it can interfere with normal calcium balance and lead to various health complications. Early detection and management are crucial for improving outcomes and maintaining overall health.

Causes & Symptoms

Clinical Causes: Genetic mutations that lead to uncontrolled cell growth in the parathyroid glands Inherited genetic syndromes, such as Multiple Endocrine Neoplasia (MEN) types 1 and 2A Radiation exposure to the neck area Previous history of cancer or radiation therapy in the vicinity Unknown factors, as the precise cause of parathyroid cancer remains largely unidentified

Key Symptoms: Elevated calcium levels in the blood (hypercalcemia), causing symptoms like nausea, vomiting, confusion, and fatigue A lump or swelling in the neck area Pain or discomfort in the neck or throat Weakness or fatigue Unintentional weight loss Kidney stones or increased urinary frequency Changes in mental status or cognitive function Potential symptoms related to bone pain or fractures due to calcium imbalance

Diagnostic & Treatment

Diagnosis Path: Diagnosing parathyroid cancer involves a combination of physical exams, laboratory tests, imaging studies, and sometimes biopsy. Key diagnostic steps include: - Blood tests to measure calcium and parathyroid hormone levels - Imaging tests such as ultrasound, sestamibi scan, or MRI to locate tumors - Fine-needle aspiration biopsy (although it may be inconclusive for cancer) - Assessing for signs of metastasis or spread to other parts of the body Early diagnosis can be challenging due to the overlap of symptoms with benign parathyroid conditions, emphasizing the importance of comprehensive evaluation by healthcare professionals.

Treatment Protocols: Treatment options for malignant neoplasm of the parathyroid gland typically involve surgical intervention, which may include: - Parathyroidectomy: Removal of the affected gland(s) - Additional procedures if cancer has spread to nearby tissues or lymph nodes Complementary therapies might include: - Radiation therapy to control tumor growth or address residual disease - Medical management to address hypercalcemia and related symptoms - Chemotherapy is generally less effective but may be considered in advanced cases Ongoing monitoring and follow-up are vital to detect recurrence or treatment-related complications promptly.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C75.0 a billable ICD-10 code?
Yes, C75.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C75.0?
Clinical documentation must specify the nature of Malignant neoplasm of parathyroid gland and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

gland neoplasm parathyroid malignant